G1 THERAPEUTICS INC (GTHX)

US3621LQ1099 - Common Stock

4.32  -0.15 (-3.36%)

After market: 4.32 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
82.51M51.30M31.48M45.29M0.00
Cost Of Goods
7.20M3.75M2.02MN/AN/A
Gross Profit
75.32M47.55M29.46MN/AN/A
Operating Expenses
114.84M183.73M171.91M141.76M129.04M
Research and Development
43.71M82.70M75.43M72.32M88.39M
Selling, General, and Administrative Expenses
71.13M101.03M96.49M69.45M40.65M
Operating Income
-39.53M-136.18M-142.46M-96.48M-129.04M
Interest Income/Expense
-7.57M-9.68M-4.62M-830.00KN/A
Other Income/Expense
2.24M0.00-550.00K-540.00K6.59M
Non Recurring Items
N/AN/A200.00KN/AN/A
Income Before Taxes
-44.85M-145.86M-147.43M-97.84M-122.45M
Income Tax
3.12M1.70M930.00K1.41MN/A
Net Income
-47.97M-147.56M-148.35M-99.25M-122.45M
EBITDA
-39.01M-135.65M-141.99M-95.90M-128.68M
 
Per Share Data
EPS Diluted Total Ops
-0.93-3.38-3.54-2.62-3.27
Non GAAP EPS
-0.95-3.39-3.53-2.63-3.26
 
Statistics
Gross Profit Margin
91.28%92.69%93.58%N/AN/A
Profit Margin
-58.13%-287.64%-471.25%-219.14%N/A
Operating Profit Margin
-47.91%-265.46%-452.54%-213.03%N/A

All data in USD

Charts